Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
Methoxymethylenedioxyamphetamine
CHF 61.50
Auf Lager
SKU
VVCMCT6P48N
1 Verfügbar 
Geliefert zwischen Mi., 19.11.2025 und Do., 20.11.2025
Details
MMDA, or 3-methoxy-4,5-methylenedioxyamphetamine, is a stimulant, a psychedelic drug, an entheogen, and an entactogen. It is a substituted amphetamine and an analogue of MDA, lophophine and MDMA (Ecstasy). It bears resemblance to the psychopharmacologically active essential oils elemicin and myristicin found in nutmeg. MMDA is most typically taken orally (as pressed tablets) or intranasally (as a powder). MMDA was written up by Alexander Shulgin in his book, PiHKAL (Phenethylamines i Have Known And Loved). Shulgin lists the dosage range of MMDA as 100-250mg. The first symptoms appear within 30-60 minutes following oral administration. MMDA causes accentuation of feelings such as anxiety, euphoria, loneliness, and loving warmth. MMDA also produces eyes-closed visuals, a state of drowsiness and muscular relaxation, and time distortion. Side effects include moderate mydriasis, dizziness, sensations of heat or cold, and trembling. The imagery is generally realistic, and often related to everyday perception of people, landscapes, or objects.
Weitere Informationen
- Allgemeine Informationen
- Editor Frederic P. Miller, Agnes F. Vandome, John McBrewster
- Titel Methoxymethylenedioxyamphetamine
- Format Fachbuch
- EAN 9786130668884
- Genre Medizin
- Anzahl Seiten 168
- Herausgeber Alphascript Publishing
- GTIN 09786130668884
Bewertungen
Schreiben Sie eine Bewertung
